RecruitingNCT04947813

Genotype-Phenotype Correlations in Patients With Alport Syndrome

Association Analysis Between Variants of COL4A3/COL4A4/COL4A5 and Alport Syndrome in the Han Chinese Population


Sponsor

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Enrollment

8,165 participants

Start Date

Jan 1, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

Alport syndrome (AS) is caused by pathogenic variants in the type IV collagen genes COL4A3, COL4A4, and COL4A5. This study aims to enroll families and patients with a history of renal hematuria in 27 hospitals and detect these three genes for AS screening. This study also aims to analysis the effect of COL4A3/COL4A4/COL4A5 genotype on the development of kidney disease.


Eligibility

Inclusion Criteria4

  • Age: up to 99 Years (Child, Adult, Older Adult)
  • Sex: All;
  • Families and patients with a history of renal hematuria;
  • Those who signed the informed consent.

Exclusion Criteria3

  • Polycystic kidney disease, hypertensive nephropathy, etc.;
  • Kidney biopsy is diagnosed as other primary/secondary kidney disease without type IV collagen-related kidney disease, including IgA nephropathy, membranous nephropathy, lupus nephritis, etc.
  • Incomplete medical history or clinical data.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

China Xinhua Hospital, Shanghai Jiao Tong University School of Medicine.

Shanghai, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04947813


Related Trials